SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human tumors and is regulated by hypoxia

Oncogene

Volumn 22, Issue 18, 2003, Pages 2823-2835

  Bowers, Alex J ^a   Scully, Sheila ^a   Boylan, John F ^a  

^a AMGEN INC   (United States)

Author keywords

ATF4; Gene expression; Hypoxia; SKIP3; Tumor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; GENE PRODUCT; MESSENGER RNA; PHOSPHOTRANSFERASE; PROTEIN SKIP3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADAPTATION; ARTICLE; BREAST TUMOR; CANCER GROWTH; CELL CYCLE; CELL GROWTH; COLON TUMOR; CONTROLLED STUDY; DISEASE ASSOCIATION; DROSOPHILA; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; LIVER TUMOR; LUNG TUMOR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; SOLID TUMOR; SURVIVAL; TISSUE DISTRIBUTION; TUMOR CELL; TWO HYBRID SYSTEM; UPREGULATION;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL CYCLE PROTEINS; CELL HYPOXIA; COLORECTAL NEOPLASMS; DNA PRIMERS; DROSOPHILA; DROSOPHILA PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

CANIS FAMILIARIS; VERTEBRATA;

EID: 0037954623     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206367     Document Type: Article

References (38)

1. Ausserer WA, Bourrat-Floeck B, Green CJ, Laderoute KR and Sutherland RM. (1994). Mol. Cell. Biol., 14, 5032-5042.
2. Butscher WG, Powers C, Olive M, Vinson C and Gardner K. (1998). J. Biol. Chem., 273, 552-560.
3. Eddy SR. (1996). Curr. Opin. Struct. Biol., 6, 361-365.
4. Estes SD, Stoler DL and Anderson GR. (1995). Exp. Cell Res., 220, 47-54.
5. Fafournoux P, Bruhat A and Jousse C. (2000). Biochem. J., 351, 1-12.
6. Fawcett TW, Martindale JL, Guyton KZ, Hai T and Holbrook NJ. (1999). Biochem. J., 339, 135-141.
7. Gachon F, Gaudray G, Thebault S, Basbous J, Koffi JA, Devaux C and Mesnard J. (2001). FEBS Lett., 502, 57-62.
8. Grosshans J and Wieschaus E. (2000). Cell, 101, 523-531.
9. Hai T and Curran T. (1991). Proc. Nat. Acad. Sci. USA, 88, 3720-3724.
10. Hai T and Hartman MG. (2001). Gene, 273, 1-11.
11. Hanks SK and Hunter T. (1995). FASEB J., 9, 576-596.
12. He CH, Gong P, Hu B, Stewart D, Choi ME, Choi AM and Alam J. (2001). J. Biol. Chem., 276, 20858-20865.
13. Hewes RS, Schaefer AM and Taghert PH. (2000). Genetics, 155, 1711-1723.
14. Hockel M and Vaupel P. (2001). J. Nat. Cancer Inst., 93, 266-276.
15. Karpinski BA, Morle GD, Huggenvik J, Uhler MD and Leiden JM. (1992). Proc. Nat. Acad. Sci. USA, 89, 4820-4824.
16. Kato Y, Koike Y, Tomizawa K, Ogawa S, Hosaka K, Tanaka S and Kato T. (1999). Mol. Cell. Endocrinol., 154, 151-159.
17. Kawai T, Matsumoto M, Takeda K, Sanjo H and Akira S. (1998). Mol. Cell. Biol., 18, 1642-1651.
18. Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ and Riggins GJ. (2001). J. Nat. Cancer Inst., 93, 1337-1343.
19. Lassot I, Segeral E, Berlioz-Torrent C, Durand H, Groussin L, Hai T, Benarous R and Margottin-Goguet F. (2001). Mol. Cell. Biol., 21, 2192-2202.
20. Liang G and Hai T. (1997). J. Biol. Chem., 272, 24088-24095.
21. Masuoka HC and Townes TM. (2002). Blood, 99, 736-745.
22. Mata J, Curado S, Ephrussi A and Rorth P. (2000). Cell, 101, 511-522.
23. Mayumi-Matsuda K, Kojima S, Suzuki H and Sakata T. (1999). Biochem. Biophys. Res. Commun., 258, 260-264.
24. Nishizawa M and Nagata S. (1992). FEBS Lett., 299, 36-38.
25. Novoa I, Zeng H, Harding HP and Ron D. (2001). J. Cell Biol., 153, 1011-1022.
26. Reddy TR, Tang H, Li X and Wong-Staal F. (1997). Oncogene, 14, 2785-2792.
27. Rorth P, Szabo K and Texido G. (2000). Mol. Cell, 6, 23-30.
28. Saramaki OR, Savinainen KJ, Nupponen NN, Bratt O and Visakorpi T. (2001). Cancer Genet. Cytogenet., 128, 31-34.
29. Seher TC and Leptin M. (2000). Curr. Biol., 10, 623-629.
30. Semenza GL. (2000). Genes and Dev., 14, 1983-1991.
31. Tang K, Finley Jr RL, Nie D and Honn KV. (2000). Biochemistry, 39, 3185-3191.
32. Vallejo M, Ron D, Miller CP and Habener JF. (1993). Proc. Nat. Acad. Sci. USA, 90, 4679-4683.
33. Vinson CR, Hai T and Boyd SM. (1993). Genes Dev., 7, 1047-1058.
34. Wadle A, Thiel G, Mischo A, Jung V, Pfreundschuh M and Renner C. (2001). Oncogene, 20, 5920-5929.
35. Wilcox JN. (1993). J. Histochem. Cytochem., 41, 1725-1733.
36. Wilkin F, Suarez-Huerta N, Robaye B, Peetermans J, Libert F, Dumont JE and Maenhaut C. (1997). Eur. J. Biochem., 248, 660-668.
37. Yao KS, Clayton M and O'Dwyer PJ. (1995). J. Nat. Cancer Inst., 87, 117-122.
38. Yao KS, Xanthoudakis S, Curran T and O'Dwyer PJ. (1994). Mol. Cell. Biol., 14, 5997-6003.